June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
In Vivo Confocal Microscopy Demonstrates Increased Density of Immune Dendritiform Cells in the Peripheral Cornea of Patients with Dry Eye Disease Compared to Normal Controls
Author Affiliations & Notes
  • Anam Akhlaq
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
  • Paula Kataguiri
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
  • Gabriela Dieckmann
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
  • Arsia Jamali
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
  • Shruti Aggarwal
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Rodrigo T Muller
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Bernardo Cavalcanti
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Yureeda Qazi
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Andrea Cruzat
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Ahmad Kheirkhah
    Cornea and Refractive Surgery Service, Massachusetts Eye & Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Pedram Hamrah
    Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Center for Translational Ocular Immunology, Tufts Medical Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Anam Akhlaq, None; Paula Kataguiri, None; Gabriela Dieckmann, None; Arsia Jamali, None; Shruti Aggarwal, None; Rodrigo Muller, None; Bernardo Cavalcanti, None; Yureeda Qazi, None; Andrea Cruzat, None; Ahmad Kheirkhah, None; Pedram Hamrah, Alcon (F), Allergan (C), Allergan (F), Bausch & Lomb (C), Dompe (C), Dompe (F), Eyegate Pharmaceuticals (C), GlaxoSmithKline (C), GlaxoSmithKline (F), Heidelberg Engineering (C), Jade Pharmaceuticals (C), Novabay (C), Santen Inc. (C), Shire (C), Shire (F), Stemnion (C), Tissue-Tech (C), Tissue-Tech (F), Valeant (C)
  • Footnotes
    Support  Allergan, Inc., Irvine, CA; NIH R01-EY022695, Massachusetts Lions Eye Foundation
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2657. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Anam Akhlaq, Paula Kataguiri, Gabriela Dieckmann, Arsia Jamali, Shruti Aggarwal, Rodrigo T Muller, Bernardo Cavalcanti, Yureeda Qazi, Andrea Cruzat, Ahmad Kheirkhah, Pedram Hamrah; In Vivo Confocal Microscopy Demonstrates Increased Density of Immune Dendritiform Cells in the Peripheral Cornea of Patients with Dry Eye Disease Compared to Normal Controls. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2657.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In vivo confocal microscopy (IVCM) is a non-invasive instrument for detecting dry eye-associated subclinical inflammation. The purpose of this study was to assess inflammatory changes in the peripheral cornea by analyzing epithelial immune dendritiform cell (DC) density and morphology in DED as compared to normal controls.

Methods : This is a prospective, cross-sectional, case-control study evaluating 46 patients with DED and 20 age and sex-matched controls (p>0.05). All 4 peripheral corneal quadrants (superior, inferior, temporal and nasal) were imaged by laser IVCM. Three representative images were analyzed for DC density and morphology (DC area and DC field) by two observers in a masked fashion. A p-value <0.05 was considered statistically significant.

Results : The mean age of DED group was 54.30±11 and that of normal controls was 49.05±9.7 years, respectively (p>0.05). DC density, DC area and DC field in the peripheral corneal quadrants ranged from 49.23±49.12 to 84.73±77.78 cells/mm2, 145.89±52.17 to 150.91±62.72m2, and 208.53±115.31 to 351.97±286.51m2. There was a significant difference in DC density between DED and controls groups for all quadrants (p<0.05). In contrast, the morphological parameters did not show statistically significant changes between the quadrants (p>0.05). DC parameters did not show statistically significant differences between evaporative and mixed subtypes of DED for any peripheral quadrant. Although mean DC density was higher in DED than in controls for all quadrants, the inferior quadrant showed increased DC density in 68% (1 SD above normal) and 48% (2 SD above normal) of patients. The nasal, temporal and superior quadrants demonstrated increased DC density between 37% and 43% (1 SD above normal), and between 14.8% and 27% (2 SD above normal) in DED.

Conclusions : The peripheral cornea demonstrates increased level of immune cell alterations in DED compared to controls, with the inferior cornea showing the highest level of subclinical inflammation. While inflammation cannot be detected by clinical examination, IVCM may be used to stratify DED patients with immune cell alterations for clinical trials or anti-inflammatory therapy.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×